Advertisement

Topics

Successful clinical trial for ovarian cancer drug

06:04 EDT 20 Jun 2017 | SmartBrief

Clovis Oncology announced positive results from a late-stage clinical trial of ovarian cancer PARP inhibitor Rubraca, in hope -More

Original Article: Successful clinical trial for ovarian cancer drug

NEXT ARTICLE

More From BioPortfolio on "Successful clinical trial for ovarian cancer drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Ovarian Cancer
Ovarian Cancer is cancer that starts in the female reproductive organs, the ovaries. It is the fifth most common cancer among women.  Women at risk of Ovarian Cancer are those who have had few children (or had children at an older age), carriers o...